Who owns TAK
349 institutions reported holding TAK for 2026Q1, together 6.2% of the company, more than the 341 a quarter earlier.
349
Institutions reporting a position · as of 2026Q1 · up from 341 the quarter before
- Shares held by institutions
- 97.9M
Shares held by institutions · 6.2% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $1.81B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 2.8%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 55
- Positions exited
- 46
- Added to
- 168
- Reduced
- 50
- Top 10 holdersof the company
- 3.9%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 349 | 97.9M | $1.81B |
| 2025Q4 | 341 | 83.6M | $1.30B |
| 2025Q3 | 325 | 85.1M | $1.25B |
| 2025Q2 | 311 | 77.8M | $1.20B |
| 2025Q1 | 305 | 71.0M | $1.06B |
| 2024Q4 | 297 | 71.9M | $952M |
| 2024Q3 | 297 | 76.2M | $1.02B |
| 2024Q2 | 281 | 72.1M | $1.14B |
| 2024Q1 | 310 | 78.2M | $1.09B |
| 2023Q4 | 300 | 83.3M | $1.19B |
| 2023Q3 | 306 | 80.1M | $1.24B |
| 2023Q2 | 306 | 83.8M | $1.32B |
| 2023Q1 | 299 | 86.7M | $1.37B |
| 2022Q4 | 278 | 67.7M | $1.06B |
| 2022Q3 | 275 | 63.6M | $826M |
| 2022Q2 | 280 | 56.7M | $795M |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Capital Research Global Investors | 19.1M | 1.2% | $354M |
| FMR LLC | 7.1M | 0.45% | $132M |
| MORGAN STANLEY | 6.5M | 0.41% | $120M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.4M | 0.41% | $119M |
| GOLDMAN SACHS GROUP INC | 5.6M | 0.36% | $104M |
| BRANDES INVESTMENT PARTNERS, LP | 4.4M | 0.28% | $82M |
| BlackRock Inc. | 3.2M | 0.20% | $59M |
| ARROWSTREET CAPITAL LIMITED PARTNERSHIP | 3.1M | 0.20% | $58M |
| RENAISSANCE TECHNOLOGIES LLC | 3.0M | 0.19% | $55M |
| UBS Group AG | 2.7M | 0.17% | $51M |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - Specialty & Generic
Ranks #14 of 28 by Smart Score